The lack of vasoconstrictor effect of the pineal hormone melatonin in an animal model predictive of antimigraine activity

Cephalalgia

Volumn 21, Issue 6, 2001, Pages 656-663

  Tom, B ^a   De Vries, P ^a   Heiligers, J P C ^a   Willems, E W ^a   Scalbert, E ^b   Delagrange, P ^b   Saxena, Pramod R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Arteriovenous anastomoses; Carotid blood flow; Melatonin; Migraine; Pig

Indexed keywords

MELATONIN; PINEAL BODY HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS FISTULA; ARTERY BLOOD FLOW; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG ACTIVITY; HEMODYNAMICS; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; VASOCONSTRICTION;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; MELATONIN; MIGRAINE DISORDERS; PINEAL GLAND; REGIONAL BLOOD FLOW; SWINE; VASOCONSTRICTION;

EID: 0034885440     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2001.00215.x     Document Type: Article

References (49)

1. 1-like receptor in dog isolated saphenous vein
2. A rational approach to identifying a fundamentally new drug for the treatment of migraine
3. From serotonin receptor classification to the antimigraine drug sumatriptan
4. Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy
5. Treatment of migraine attacks with sumatriptan
6. Sumatriptan in clinical practice: A 2-year review of 453 migraine patients
7. 1B/1Dreceptor agonists in the acute treatment of migraine
8. 1F receptor agonists in human and bovine cerebral arteries: Similarity with human coronary artery
9. 1B receptor-mediated contractions in human temporal artery: Evidence from selective antagonists and 5-HT receptor mRNA expression
10. 1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses
11. Pharmacology of triptans
12. 1B/1D receptor agonists in migraine. Comparative pharmacology and its therapeutic implications
13. Coronary side-effect potential of current and prospective antimigraine drugs
14. Melatonin receptor ligands and their potential clinical applications
15. Melatonin, its receptors, and relationships with biological rhythm disorders
16. GR196429: A nonindolic agonist at high-affinity melatonin receptors
17. 1 melatonin receptor partial agonists, antagonists, and putative inverse agonists
18. Role of the suprachiasmatic nucleus in the pathogenesis of migraine attacks
19. Pathophysiological aspects of menstrual migraine
20. Is migraine due to a deficiency of pineal melatonin?
21. Nocturnal plasma melatonin levels in migraine: A preliminary report
22. Nocturnal plasma melatonin profile and melatonin kinetics during infusion in stares migrainosus
23. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine
24. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses
25. Vascular melatonin receptors
26. Melatonin receptors mediate contraction of a rat cerebral artery
27. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats
28. Melatonin modulates vascular smooth muscle tone
29. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels
30. Evidence for direct vasoconstrictor activity of melatonin in 'pressurized' segments of isolated caudal artery from juvenile rats
31. Pathogenesis of migraine
32. Cranial arteriovenous shunting, an in vivo animal model for migraine
33. On the preservation and regulation of vascular tone in arteriovenous anastomoses during anesthesia
34. Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances
35. Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow
36. Reduction of regional cerebral blood flow by melatonin in young rats
37. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats
38. Proceedings. The effect of melatonin on pinealectomy-induced hypertension in the rat
39. Antihypertensive action of melatonin in the spontaneously hypertensive rat
40. Suppression of sympathetic nervous system by short photoperiod and melatonin in the Syrian hamster
41. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men
42. Vasorelaxing action of melatonin in rabbit basilar artery
43. Vasorelaxing action of melatonin in rat isolated aorta; possible endothelium dependent relaxation
44. The mode of vasorelaxing action of melatonin in rabbit aorta
45. Pharmacological studies on the inhibitory action of melatonin and putative melatonin analogues on porcine vascular smooth muscle
46. Melatonin improves cerebral circulation security margin in rats
47. + channels and endothelial factors
48. Melatonin mediates vascular dilatation via a distinct melatonin receptor sub-type